Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 18802150

Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2008 Sep 20
First author
Paulussen M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2009 May;6(5):251-3. doi: 10.1038/nrclinonc.2009.25.
    note
    Source null
    related pmid
    19390548
    relationship
    Comment in

Authors and identifiers

  1. name
    Paulussen M
    type
    Author
  2. name
    Craft AW
    type
    Author
  3. name
    Lewis I
    type
    Author
  4. name
    Hackshaw A
    type
    Author
  5. name
    Douglas C
    type
    Author
  6. name
    Dunst J
    type
    Author
  7. name
    Schuck A
    type
    Author
  8. name
    Winkelmann W
    type
    Author
  9. name
    Köhler G
    type
    Author
  10. name
    Poremba C
    type
    Author
  11. name
    Zoubek A
    type
    Author
  12. name
    Ladenstein R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Paulussen M
    type
    Author
  2. name
    Craft AW
    type
    Author
  3. name
    Lewis I
    type
    Author
  4. name
    Hackshaw A
    type
    Author
  5. name
    Douglas C
    type
    Author
  6. name
    Dunst J
    type
    Author
  7. name
    Schuck A
    type
    Author
  8. name
    Winkelmann W
    type
    Author
  9. name
    Köhler G
    type
    Author
  10. name
    Poremba C
    type
    Author
  11. name
    Zoubek A
    type
    Author
  12. name
    Ladenstein R
    type
    Author
bibliography ids
  1. nci-bib-a71816ad6f1a16c0db32363d
book metadata
content sha256
0a2b42ad82f9ebee902725677d3bf043c359284c3cab7e163ba2e2db1007d159
document type
citation
dois
  1. 10.1200/JCO.2008.16.5720
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:18802150
immutable id
pubmed:18802150@0a2b42ad82f9ebee902725677d3bf043c359284c3cab7e163ba2e2db1007d159
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
27
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
4385-93
volume
26
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2009 May;6(5):251-3. doi: 10.1038/nrclinonc.2009.25.
    note
    Source null
    related pmid
    19390548
    relationship
    Comment in
outcomes validated
false
pmid
18802150
provenance
batch id
6281e3e555c9a831cffc
provider
NCBI PubMed ESummary
record sha256
7ad54afdae970aad54beb683656090cd5dddb422dcbf2aeb899a2c28447e2700
response sha256
0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
retrieved at
2026-09-09T23:46:21.772457+00:00
publication date
display
2008 Sep 20
precision
day
year
2008
publication types
  1. Comparative Study
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/18802150/
title
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.

Preserved source evidence · Not medical advice